4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:分子类,蛋白类,抗体类,生化类试剂
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > peptide > bioporto/Anti-Pregnancy associated plasma protein A (human, PAPP-A)/1kit/BTE 004-09
商品详细bioporto/Anti-Pregnancy associated plasma protein A (human, PAPP-A)/1kit/BTE 004-09
bioporto/Anti-Pregnancy associated plasma protein A (human, PAPP-A)/1kit/BTE 004-09
bioporto/Anti-Pregnancy associated plasma protein A (human, PAPP-A)/1kit/BTE 004-09
商品编号: BTE004-09
市场价: ¥0.00
美元价: 0.00
产地: 美国(厂家直采)
公司:
产品分类: 多肽合成
公司分类: peptide
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
Cat. No.
BTE 004-09
Specificity
BTE 004-09 is specific for native human PAPP-A. Heat and SDS denatured PAPP-A is also recognized, but not acid treated PAPP-A.
Immunogen
Purified human PAPP-A
Host
Mouse
Positive Species Reactivity
Human
Negative Species Reactivity
Not determined
Isotype
IgG2b/k
Gene ID
5069
Clone Number
9
Epitope Specificity
The epitope of BTE 004-09 is different from ABS 006-01 and ABS 006-24. The epitope is located on the PAPP-A subunit of the heterotetramer.
Unit Size
200 µL: Cat. No. BTE 004-09-021 mL: Cat. No. BTE 004-09-11 mg/mL +/- 15%. See Certificate of Analysis for details.
Purification
protein A/G purified (from culture supernatant)
Form
Liquid
Solvent
0.01 M phosphate buffer, pH 7.4, containing 0.5 M NaCl and 15 mM sodium azide
Conjugation
Unconjugated BSA free
Storage
4-8ºC without exposure to light. No precautions necessary during handling.
Target
Pregnancy-associated plasma protein-A (PAPP-A, Insulin-like growth factor binding protein-4 protease, PAPP-A-proMBP complex) is a large heterotetrameric glycoprotein of approximately 500 kDa, which was first discovered in serum from pregnant women. The hetreotetramer consists of two PAPP-A subunits and two proMBP subunits. Low maternal serum levels of PAPP-A in first trimester biochemical screening is used as a marker of Down’s syndrome (trisomy 21).
品牌介绍
  丹麦Bioporto公司成立于2000年,致力于开发抗体产品及诊断试剂盒。2005年首次开发出NGAL ELISA 试剂盒,该产品于2006年获得欧盟CE认证,可用于急性肾功能损伤的临床诊断和监测。其目标是开发出更多的临床诊断专利产品。